相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。TRIM17 and TRIM28 antagonistically regulate the ubiquitination and anti-apoptotic activity of BCL2A1
Loic Lionnard et al.
CELL DEATH AND DIFFERENTIATION (2019)
The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program
Abhijit Parolia et al.
MOLECULAR ONCOLOGY (2019)
LINC00162 confers sensitivity to 5-Aza-2′-deoxycytidine via modulation of an RNA splicing protein, HNRNPH1
Liang Zong et al.
ONCOGENE (2019)
LncRNA H19 overexpression induces bortezomib resistance in multiple myeloma by targeting MCL-1 via miR-29b-3p
Yafang Pan et al.
CELL DEATH & DISEASE (2019)
Aggressive variants of prostate cancer - Are we ready to apply specific treatment right now?
Igor Tsaur et al.
CANCER TREATMENT REVIEWS (2019)
A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma
Wei Zhai et al.
MOLECULAR CANCER (2019)
H19 lncRNA identified as a master regulator of genes that drive uterine leiomyomas
Tiefeng Cao et al.
ONCOGENE (2019)
A long noncoding RNA distributed in both nucleus and cytoplasm operates in the PYCARD-regulated apoptosis by coordinating the epigenetic and translational regulation
Hui Miao et al.
PLOS GENETICS (2019)
Long noncoding RNA H19 promotes chemotherapy resistance in choriocarcinoma cells
Shuran Yu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Long noncoding RNA PCAT6 inhibits colon cancer cell apoptosis by regulating anti-apoptotic protein ARC expression via EZH2
Weimei Huang et al.
CELL CYCLE (2019)
Long Noncoding RNA LBCS Inhibits Self-Renewal and Chemoresistance of Bladder Cancer Stem Cells through Epigenetic Silencing of SOX2
Xu Chen et al.
CLINICAL CANCER RESEARCH (2019)
Long non-coding RNA H19 and cancer: A competing endogenous RNA
Yafen Ye et al.
BULLETIN DU CANCER (2019)
Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1
Mei Xu et al.
MOLECULAR CARCINOGENESIS (2019)
A randomized phase 2 study of a HSP27 targeting antisense, apatorsen with prednisone versus prednisone alone, in patients with metastatic castration resistant prostate cancer
Evan Y. Yu et al.
INVESTIGATIONAL NEW DRUGS (2018)
LncRNA H19 interacts with S-adenosylhomocysteine hydrolase to regulate LINE-1 Methylation in human lung-derived cells exposed to Benzo[a]pyrene
Ye Fu et al.
CHEMOSPHERE (2018)
Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
Maha Hussain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Hypoxia and Noncoding RNAs in Taxane Resistance
Perla Pucci et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2018)
LncRNA SNHG7 sponges miR-216b to promote proliferation and liver metastasis of colorectal cancer through upregulating GALNT1
Yujia Shan et al.
CELL DEATH & DISEASE (2018)
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer
Weilong Chen et al.
PLOS BIOLOGY (2018)
Long Non-coding RNA Structure and Function: Is There a Link?
Anna Zampetaki et al.
FRONTIERS IN PHYSIOLOGY (2018)
Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial
Tomasz M. Beer et al.
LANCET ONCOLOGY (2017)
MALAT1 Is Associated with Poor Response to Oxaliplatin-Based Chemotherapy in Colorectal Cancer Patients and Promotes Chemoresistance through EZH2
Peilong Li et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Long noncoding RNA EGFR-AS1 mediates epidermal growth factor receptor addiction and modulates treatment response in squamous cell carcinoma
Daniel S. W. Tan et al.
NATURE MEDICINE (2017)
Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes
Leslimar Rios-Colon et al.
ONCOTARGET (2017)
Up-regulation of LINC00161 correlates with tumor migration and invasion and poor prognosis of patients with hepatocellular carcinoma
Li-Chao Xu et al.
ONCOTARGET (2017)
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer
J. Bellmunt et al.
ANNALS OF ONCOLOGY (2017)
βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel
Gregoriy Smiyun et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2017)
TWIST1-WDR5-Hottip Regulates Hoxa9 Chromatin to Facilitate Prostate Cancer Metastasis
Reem Malek et al.
CANCER RESEARCH (2017)
Androgen-induced lncRNA POTEF-AS1 regulates apoptosis-related pathway to facilitate cell survival in prostate cancer cells
Aya Misawa et al.
CANCER SCIENCE (2017)
Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis
Yuan Wang et al.
CANCER LETTERS (2016)
Fisetin Enhances Chemotherapeutic Effect of Cabazitaxel against Human Prostate Cancer Cells
Eiman Mukhtar et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Substantial interindividual and limited intraindividual genomic diversity among tumors from men with metastatic prostate cancer
Akash Kumar et al.
NATURE MEDICINE (2016)
Resistance to docetaxel in prostate cancer is associated with androgen receptor activation and loss of KDM5D expression
Kazumasa Komura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Combination effect of therapies targeting the PI3K-and AR-signaling pathways in prostate cancer
Shalini Singh Yadav et al.
ONCOTARGET (2016)
Immunohistochemical staining of ERG and SOX9 as potential biomarkers of docetaxel response in patients with metastatic castration-resistant prostate cancer
Wan Song et al.
ONCOTARGET (2016)
LncRNA H19 confers chemoresistance in ERα-positive breast cancer through epigenetic silencing of the pro-apoptotic gene BIK
Xinxin Si et al.
ONCOTARGET (2016)
The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients
Chun-yang Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Clinical Pharmacokinetic Studies of Enzalutamide
Jacqueline A. Gibbons et al.
CLINICAL PHARMACOKINETICS (2015)
The landscape of long noncoding RNAs in the human transcriptome
Matthew K. Iyer et al.
NATURE GENETICS (2015)
N-terminal targeting of androgen receptor variant enhances response of castration resistant prostate cancer to taxane chemotherapy
Sarah K. Martin et al.
MOLECULAR ONCOLOGY (2015)
Aggressive Variants of Castration-Resistant Prostate Cancer
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2014)
Obatoclax overcomes resistance to cell death in aggressive thyroid carcinomas by countering Bcl2a1 and Mcl1 overexpression
Devora Champa et al.
ENDOCRINE-RELATED CANCER (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy REPLY
Tomasz M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
The long non-coding RNA Dali is an epigenetic regulator of neural differentiation
Vladislava Chalei et al.
ELIFE (2014)
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
T. M. Beer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Platinum-Based Chemotherapy for Variant Castrate-Resistant Prostate Cancer
Ana M. Aparicio et al.
CLINICAL CANCER RESEARCH (2013)
Cabazitaxel in patients with advanced solid tumours: Results of a Phase I and pharmacokinetic study
V. Dieras et al.
EUROPEAN JOURNAL OF CANCER (2013)
Optimization of the Transductional Efficiency of Lentiviral Vectors: Effect of Sera and Polycations
Warren Denning et al.
MOLECULAR BIOTECHNOLOGY (2013)
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
Charles J. Ryan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prostate cancer progression after androgen deprivation therapy: mechanisms of castrate resistance and novel therapeutic approaches
T. Karantanos et al.
ONCOGENE (2013)
Androgen Receptor Promotes Ligand-Independent Prostate Cancer Progression through c-Myc Upregulation
Lina Gao et al.
PLOS ONE (2013)
BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition
Rizwan Haq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1, and androgen receptor
Masaki Shiota et al.
PROSTATE (2013)
BCL2A1: the underdog in the BCL2 family
M. Vogler
CELL DEATH AND DIFFERENTIATION (2012)
Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
Howard I. Scher et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Phase II study of carboplatin and etoposide in patients with anaplastic progressive metastatic castration-resistant prostate cancer (mCRPC) with or without neuroendocrine differentiation: results of the French Genito-Urinary Tumor Group (GETUG) P01 trial
A. Flechon et al.
ANNALS OF ONCOLOGY (2011)
Characterising the castration-resistant prostate cancer population: a systematic review
M. Kirby et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
DNA Nuclear Targeting Sequences for Non-Viral Gene Delivery
Ethlinn V. B. van Gaal et al.
PHARMACEUTICAL RESEARCH (2011)
Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial
Johann Sebastian de Bono et al.
LANCET (2010)
The anti-apoptotic gene BCL2A1 is a novel transcriptional target of PU.1
M. Jenal et al.
LEUKEMIA (2010)
Cabazitaxel boosts post-docetaxel survival
Lisa Richards
Nature Reviews Urology (2010)
Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells
R. A. C. McPherson et al.
BRITISH JOURNAL OF CANCER (2009)
Tissue Culture Media Supplemented With 10% Fetal Calf Serum Contains a Castrate Level of Testosterone
J. P. Michiel Sedelaar et al.
PROSTATE (2009)
Intracellular trafficking of plasmids during transfection is mediated by microtubules
EE Vaughan et al.
MOLECULAR THERAPY (2006)
Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer
DP Petrylak et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Direct effect of taxol on free radical formation and mitochondrial permeability transition
G Varbiro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2001)
Carboplatin pharmacokinetics in patients receiving carboplatin and paclitaxel/docetaxel for advanced lung cancers: impact of age and renal function on area under the curve
W Kern et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2001)
分享论文
